文献速递妇科产科

上皮性卵巢癌淋巴结孤立肿瘤细胞的生存与临床病理特征评估

Assessment of survival and clinicopathologic characteristics associated with lymph node isolated tumor cells in epithelial ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2026-03-09

该回顾性队列研究基于美国国家癌症数据库2018至2023年15484例上皮性卵巢癌患者,分析淋巴结孤立肿瘤细胞(ITC)的发病率、特征及生存关联。结果显示ITC总体发生率为1.0%,与更高T分期和低级别浆液性癌相关,但多变量分析中ITC与总生存无统计学显著关联。

要点

  • 上皮性卵巢癌区域淋巴结ITC发生率为1.0%。
  • ITC发生率随T分期升高而增加,低级别浆液性癌中更高。
  • ITC与总生存无统计学显著关联。

核心结论

  • 区域淋巴结ITC可能不是上皮性卵巢癌短期生存的预后因素。

研究设计与样本

  • 回顾性队列研究,查询美国癌症委员会国家癌症数据库,纳入15484例T1-T3/N0-N0(i+)/M0期上皮性卵巢癌患者。

主要发现

  • 157例(1.0%)患者区域淋巴结存在ITC。
  • T1、T2、T3期ITC发生率分别为0.5%、1.2%、2.6%;T2 vs T1的aOR为1.90(95%CI 1.21-3.00),T3 vs T1的aOR为3.45(95%CI 2.29-5.20)。
  • 低级别浆液性癌ITC发生率4.0%,高级别浆液性癌1.5%,aOR为2.68(95%CI 1.66-4.31)。
  • ITC与总生存无统计学显著关联:4年生存率81.0% vs 86.7%,调整后HR 0.94(95%CI 0.58-1.52)。
  • 亚组分析结果相似,包括T1期调整后HR 1.26(95%CI 0.40-3.93)。

临床怎么用

  • 对于上皮性卵巢癌区域淋巴结ITC,可结合T分期和病理类型综合评估,但不宜仅凭ITC判断短期预后。

局限性

  • 回顾性研究设计可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess reported incidences, characteristics, and survival associated with isolated tumor cells (ITCs) in epithelial ovarian cancer. METHODS: This retrospective cohort study queried the Commission-on-Cancer's National Cancer Database. The study population included 15,484 patients with epithelial ovarian cancer and American Joint Committee on Cancer classification T1-T3 / N0-N0(i+) / M0 who had lymph node evaluation at primary anti-cancer surgery from 2018 to 2023. Multivariable Cox proportional hazards regression model was created to assess overall survival (OS) associated with ITCs, adjusting for preoperative and intraoperative factors-derived propensity score and further postoperative chemotherapy. RESULTS: A total of 157 (1.0%) patients had ITCs in regional lymph nodes, corresponding to one in 100 patients. Higher T classification was associated with higher incidence rate of ITCs (0.5%, 1.2%, and 2.6% for T1, T2, and T3 classification, respectively; adjusted-odd ratio [aOR] for T2 vs T1, 1.90, 95% confidence interval [CI] 1.21 to 3.00; and aOR for T3 vs T1 3.45, 95%Cl 2.29 to 5.20). Reported incidence rates of ITCs were higher for low-grade serous carcinoma compared to high-grade serous carcinoma (4.0% vs 1.5%, aOR 2.68, 95%Cl 1.66 to 4.31). In multivariable analysis, ITCs were statistically not associated with OS (4-year rates, 81.0% and 86.7%, adjusted-hazard ratio 0.94, 95%Cl 0.58 to 1.52). Results were similar in several subgroups (age < 60, age ≥ 60, T1, T2, and T3 classifications, high-grade serous, and low-grade serous) in exploratory analysis. This included adjusted-hazard ratio of 1.26 (95%CI 0.40 to 3.93) for T1 classification. CONCLUSION: The results of this cohort study suggest that ITCs in the regional lymph node may not be a prognostic factor for short-term survival in epithelial ovarian cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Lee MW, Friedman EL, Erfani H, et al. Assessment of survival and clinicopathologic characteristics associated with lymph node isolated tumor cells in epithelial ovarian cancer. Gynecol Oncol. 2026. PMID: 41806549. doi:10.1016/j.ygyno.2026.02.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。